Arsenic Poisoning Clinical Trial
Official title:
Efficacy and Safety of Folic Acid Supplementation Lowering Arsenic in a Chronic, Low-level Exposed Arsenic Population: a Randomized, Double-blind, Placebo Controlled Clinical Trial.
The purpose of this study is to determine whether folic acid supplementation are effective on arsenic lowering in a chronic, low-level arsenic exposed population.
Outcome measure:
Changes of arsenic metabolites at baseline and week 8
Methods High-performance liquid chromatography (HPLC)
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02429921 -
High-selenium Lentils Versus Arsenic Toxicity
|
N/A | |
Active, not recruiting |
NCT03725592 -
Strong Heart Water Study
|
N/A | |
Completed |
NCT01442727 -
Selenium in the Treatment of Arsenic Toxicity and Cancers
|
Phase 3 |